STOCK TITAN

Cronos Group Stock Price, News & Analysis

CRON Nasdaq

Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.

Cronos Group Inc. (CRON) is a global leader in cannabis innovation, operating across medicinal and recreational markets with brands like Peace Naturals and Spinach. This page provides investors and industry observers with centralized access to official press releases, financial updates, and strategic developments.

Track CRON's progress through earnings reports, regulatory milestones, product launches, and partnership announcements. Our curated news collection ensures you stay informed about operational expansions, research breakthroughs, and market positioning in the evolving cannabis sector.

All content is sourced from verified channels to maintain accuracy and compliance with financial disclosure standards. Bookmark this page for efficient monitoring of CRON's performance across North American, European, and Australian markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.76%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.13%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.53%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Summary

Cronos Group Inc. (NASDAQ: CRON) announced its upcoming 2023 first quarter earnings conference call scheduled for May 9, 2023, at 8:30 a.m. ET. During this call, the company's senior management will discuss financial results and address questions from investors. Those interested can register for the event online, and a replay will be available on the company’s website.

Cronos is recognized as an innovative global cannabinoid company focused on developing disruptive intellectual property through cannabis research and technology. Its brand portfolio includes well-known names like Spinach®, PEACE NATURALS®, and Lord Jones®.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
-
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) has released a Sustainability Study in honor of Earth Day, highlighting the environmental benefits of its innovative fermentation manufacturing methods for cannabinoid production compared to traditional indoor cultivation methods. The study reveals that using Cronos’ fermentation techniques results in an average carbon footprint savings of 99.8% compared to conventional extraction methods, significantly reducing environmental harm across various metrics. The company’s Spinach FEELZ™ brand features products made using these sustainable methods, focusing on rare cannabinoids like CBC and CBG. Cronos aims to lead the cannabis industry towards more sustainable practices, reinforcing the importance of adopting such innovative technologies for future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
Rhea-AI Summary

Cronos Group Inc. (NASDAQ: CRON) announced an expansion of its Spinach® brand with new infused pre-roll offerings, reflecting a significant growth in market share. The Spinach® infused pre-rolls gained 2.5% market share in Q1 2023, rising to 8th place from 16th in Q4 2022. The Canadian cannabis pre-roll market grew by 38% year-over-year, with infused pre-rolls comprising approximately 24% of that share. Notable products include Spinach® Fully Charged Atomic GMO with 35% Total THC and various flavor profiles aiming to enhance consumer experience. Cronos emphasizes innovation and consumer engagement, anticipating continued growth through their new product launches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
none

FAQ

What is the current stock price of Cronos Group (CRON)?

The current stock price of Cronos Group (CRON) is $1.85 as of May 6, 2025.

What is the market cap of Cronos Group (CRON)?

The market cap of Cronos Group (CRON) is approximately 700.0M.
Cronos Group

Nasdaq:CRON

CRON Rankings

CRON Stock Data

700.03M
200.59M
46.39%
14.32%
1.19%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
STAYNER